Payment overview · 2025
General Payments
$43.65
2 reported records · 2 companies
Healthcare provider profile · identity verified
Bradley Tan, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · LAKELAND, FL · NPI 1972509495
Verified facts
What the public records show
CMS Open Payments records show Bradley Tan, M.D. received $43.65 in general payments during 2025 across 2 reported records.
PFIZER INC. accounted for 53.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 72 claims for Synthroid by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 189 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $23.28 | 53.3% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $20.37 | 46.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $43.65 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $23.28 | 1 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $23.28 | 1 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $20.37 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $20.37 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
72 | 15 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
189 | 38 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 859 | 260 |
| Alprazolam | Alprazolam | 737 | 128 |
| Atorvastatin Calcium | Atorvastatin Calcium | 733 | 206 |
| Amlodipine Besylate | Amlodipine Besylate | 717 | 212 |
| Levothyroxine Sodium | Levothyroxine Sodium | 580 | 166 |
| Lisinopril | Lisinopril | 547 | 161 |
| Metoprolol Succinate | Metoprolol Succinate | 478 | 133 |
| Pantoprazole Sodium | Pantoprazole Sodium | 403 | 106 |
| Omeprazole | Omeprazole | 368 | 112 |
| Metformin Hcl | Metformin Hcl | 336 | 103 |
| Losartan Potassium | Losartan Potassium | 328 | 95 |
| Tramadol Hcl | Tramadol Hcl | 325 | 78 |
| Gabapentin | Gabapentin | 319 | 83 |
| Glimepiride | Glimepiride | 312 | 88 |
| Irbesartan | Irbesartan | 264 | 75 |
| Metoprolol Tartrate | Metoprolol Tartrate | 257 | 75 |
| Montelukast Sodium | Montelukast Sodium | 250 | 77 |
| Tamsulosin Hcl | Tamsulosin Hcl | 247 | 72 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 242 | 64 |
| Clopidogrel | Clopidogrel Bisulfate | 235 | 61 |
| Hydralazine Hcl | Hydralazine Hcl | 233 | 65 |
| Simvastatin | Simvastatin | 201 | 59 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 197 | 67 |
| Pravastatin Sodium | Pravastatin Sodium | 192 | 52 |
| Eliquis | Apixaban | 189 | 38 |
| Tizanidine Hcl | Tizanidine Hcl | 182 | 44 |
| Furosemide | Furosemide | 172 | 61 |
| Trazodone Hcl | Trazodone Hcl | 171 | 55 |
| Pioglitazone Hcl | Pioglitazone Hcl | 150 | 47 |
| Citalopram Hbr | Citalopram Hydrobromide | 148 | 46 |
| Ezetimibe | Ezetimibe | 139 | 39 |
| Carvedilol | Carvedilol | 137 | 42 |
| Zolpidem Tartrate | Zolpidem Tartrate | 134 | 22 |
| Januvia | Sitagliptin Phosphate | 131 | 33 |
| Potassium Chloride | Potassium Chloride | 129 | 50 |
| Escitalopram Oxalate | Escitalopram Oxalate | 126 | 34 |
| Famotidine | Famotidine | 121 | 41 |
| Clonazepam | Clonazepam | 118 | 24 |
| Clonidine Hcl | Clonidine Hcl | 115 | 31 |
| Lorazepam | Lorazepam | 109 | 24 |
| Pregabalin | Pregabalin | 108 | 18 |
| Hydrochlorothiazide | Hydrochlorothiazide | 105 | 29 |
| Celecoxib | Celecoxib | 99 | 26 |
| Baclofen | Baclofen | 94 | 23 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 93 | 28 |
| Donepezil Hcl | Donepezil Hcl | 89 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 89 | 20 |
| Jardiance | Empagliflozin | 88 | 21 |
| Ozempic | Semaglutide | 86 | 26 |
| Doxazosin Mesylate | Doxazosin Mesylate | 85 | 27 |
| Trulicity | Dulaglutide | 83 | 15 |
| Allopurinol | Allopurinol | 82 | 22 |
| Sertraline Hcl | Sertraline Hcl | 82 | 28 |
| Bumetanide | Bumetanide | 80 | 21 |
| Jantoven | Warfarin Sodium | 80 | 12 |
| Xarelto | Rivaroxaban | 79 | 17 |
| Fenofibrate | Fenofibrate | 77 | 24 |
| Finasteride | Finasteride | 75 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 75 | 32 |
| Atenolol | Atenolol | 73 | 19 |
| Synthroid | Levothyroxine Sodium | 72 | 15 |
| Ondansetron Hcl | Ondansetron Hcl | 69 | 29 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 68 | 21 |
| Fluoxetine Hcl | Fluoxetine Hcl | 66 | 21 |
| Warfarin Sodium | Warfarin Sodium | 66 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 65 | 16 |
| Mounjaro | Tirzepatide | 62 | 11 |
| Meclizine Hcl | Meclizine Hcl | 57 | 18 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 55 | 17 |
| Meloxicam | Meloxicam | 54 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 53 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 53 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 48 | 42 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 48 | suppressed |
| Memantine Hcl | Memantine Hcl | 48 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 48 | 11 |
| Farxiga | Dapagliflozin Propanediol | 47 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 46 | 18 |
| Digoxin | Digoxin | 43 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | 15 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 41 | suppressed |
| Temazepam | Temazepam | 39 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 38 | 31 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 38 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 38 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 36 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 36 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 35 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 35 | 13 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 35 | suppressed |
| Glipizide Er | Glipizide | 34 | suppressed |
| Azithromycin | Azithromycin | 33 | 31 |
| Bupropion Xl | Bupropion Hcl | 31 | suppressed |
| Repatha Sureclick | Evolocumab | 31 | suppressed |
| Lovastatin | Lovastatin | 30 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 30 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 29 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 28 | suppressed |
| Methylprednisolone | Methylprednisolone | 28 | 25 |
| Valsartan | Valsartan | 28 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 27 | suppressed |
| Ramipril | Ramipril | 27 | suppressed |
| Ranolazine Er | Ranolazine | 27 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 27 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 27 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 26 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 26 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 26 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 26 | suppressed |
| Sotalol | Sotalol Hcl | 26 | suppressed |
| Topiramate | Topiramate | 25 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 25 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Nitroglycerin | Nitroglycerin | 24 | 16 |
| Rybelsus | Semaglutide | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 19 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 22 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 22 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 22 | suppressed |
| Spironolactone | Spironolactone | 22 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 21 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 21 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 21 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 21 | suppressed |
| Vascepa | Icosapent Ethyl | 21 | suppressed |
| Glipizide | Glipizide | 19 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 19 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Cephalexin | Cephalexin | 18 | 18 |
| Ibuprofen | Ibuprofen | 18 | suppressed |
| Ondansetron Odt | Ondansetron | 18 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 18 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 18 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 17 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 17 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Diazepam | Diazepam | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | 14 |
| Modafinil | Modafinil | 15 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 15 | suppressed |
| Risperidone | Risperidone | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Mirtazapine | Mirtazapine | 14 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 14 | suppressed |
| Amoxicillin | Amoxicillin | 13 | 12 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Humalog Kwikpen U-200 | Insulin Lispro | 13 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Humulin R | Insulin Regular, Human | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 13 | suppressed |
| Telmisartan | Telmisartan | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Toprol Xl | Metoprolol Succinate | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Calcipotriene | Calcipotriene | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Loperamide | Loperamide Hcl | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $43.65 · 2 records | PFIZER INC. | NURTEC ODT, QULIPTA, UBRELVY, ZAVZPRET | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error